Current Neuro-Oncology
Volume
27 Number 9
31 March 2025
Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 9, 31 March
Maza EJL, Pavoni JF, Leoni RF.
Early
and late structural brain changes after radiation therapy: an MRI
study in glioma patients.
J
Neurooncol. 2025 Mar 21. doi:
10.1007/s11060-025-05008-x. PMID:
40116986. Observational study˰
ˍ
Conklin HM, Salman NA, Bass JK, Huang J, Onar-Thomas A, Ashford
JM, Harman J, Ali JS, Swain MA, Harder LL, Carlson-Green BL,
Miller JM, Wallace J, Kaner RJ, Merchant TE, Robinson GW, Gajjar
A.
Ototoxicity and Cognitive Outcomes
among Very Young Children Treated for Brain Tumors: Findings from
a Multisite, Prospective, Longitudinal Trial.
Neuro
Oncol. 2025 Mar 22:noaf073. doi:
10.1093/neuonc/noaf073. PMID:
40120120. Interventional study˰
ˍ
Oglesby RT, Pathiravasan CH, Olatunji E, Chang L, Chotiyanonta J,
Uchida Y, Lee J, Oishi K, Peterson R, Acharya S.
Characterizing
long-term neurocognitive outcomes through diffusion tensor imaging
in childhood brain tumor survivors.
Neuro
Oncol. 2025 Mar 22:noaf083. doi:
10.1093/neuonc/noaf083. PMID:
40119791. Observational study˰
ˍ
Wen PY, Manzanera A, Duault C, Gonzalez-Kozlova E, Lopez L,
Grossman SA, Ye X, Fisher J, Lee I, Walbert T, Snyder J, Brem S,
Desai A, Bagley SJ, Kakani C, Strowd R, Tatter S, Laxton A, Lesser
G, Amankulor N, Lieberman F, Drappatz J, Mantica M, Triggs D,
Haymaker C, Wistuba II, Al-Atrash G, Mendoza Perez J, Futreal A,
Little LD, Islam MDH, Duose D, Jiang P, Reuben A, Lawler SE,
Pichavant M, Gentles A, Bendall S, Kong A, Camacho C, Del Valle D,
Kim-Schulze S, Gnjatic S, Sharon E, Nowicki MO, Peruzzi P, Lane D,
Aguilar-Cordova E, Aguilar LK, Nichols G, Dwyer J, Tak PP, Maecker
H, Barone F, Chiocca EA.
A
multi-institutional phase 1 clinical trial exploring upfront
multimodal standard of care and combined immunotherapies for newly
diagnosed glioblastoma.
Neuro
Oncol. 2025 Mar 22:noaf079. doi:
10.1093/neuonc/noaf079. PMID:
40120123. Interventional study˰
ˍ
Jiang N, Xu LP, Li F, Wang PP, Cao Y.
Efficacy
and safety of simultaneous integrated boost intensity-modulated
radiotherapy combined with temozolomide for the postoperative
chemotherapy treatment of multifocal high-grade glioma.
Front
Oncol. 2025 Mar 24;15:1539362. doi:
10.3389/fonc.2025.1539362. PMID:
40196731.
Observational study. ˍ
Liu E, Su HM, Toyota P, Newton BD, Coote N, Marciniuk K, Auer RN,
Fourney DR.
H3K27M-mutant spinal cord
and hemispheric tumor with prolonged survival: illustrative case.
J
Neurosurg Case Lessons. 2025 Mar 24;9(12):CASE24668.
doi:
10.3171/CASE24668. PMID:
40127482. Case report. ˍ
Shariff
N, Moreno AS, Bennett J, Ramaswamy V, Das A, Liu AP, Huang A,
Tabori U, Hawkins C, Dirks P, Bouffet E, Keilty DM, Millar BA,
Hodgson DC, Tsang DS.
Re-irradiation
for children with diffuse intrinsic pontine glioma and diffuse
midline glioma.
Radiother
Oncol.
2025 Mar 24:110865. doi:
10.1016/j.radonc.2025.110865. PMID:
40139463. Observational study. ˍ
Kahvecioglu A, Cengiz M, Burca Aydin G, Tezer Kutluk M, Coban
Cifci G, Yazici G.
Re-irradiation in
progressive diffuse infiltrative pontine glioma in children and
young adults.
Strahlenther
Onkol. 2025 Mar 25. doi:
10.1007/s00066-025-02394-z. PMID:
40131412.
Observational study. ˍ
Gal O, Yu J, Mehta MP, Hall MD, Press RH, Odia Y, McDermott MW,
Fellows Z, Wroe A, Gutierrez AN, Kotecha R.
Contrast-enhancing
Lesions Induced by Central Nervous System-directed Intensity
Modulated Proton Therapy: Distribution Patterns, Kinetics, Risk
Factors, and Outcomes.
Int
J Radiat Oncol Biol Phys. 2025 Mar
26:S0360-3016(25)00254-8. doi:
10.1016/j.ijrobp.2025.03.025. PMID:
40154845.
Observational study˰ ˍ
Moore-Palhares D, Lawrence LS, Myrehaug S, Stewart J, Detsky J,
Tseng CL, Chen H, Dinakaran D, Maralani P, Ruschin M, Zhang B,
Perry J, Lim-Fat MJ, Sahgal A, Soliman H, Lau AZ.
Temporal
Apparent Diffusion Coefficient (ADC) Changes During
Chemoradiation: An Imaging Biomarker for Tumour Response
Monitoring and Spatial Recurrence Prediction in Glioblastoma.
Int
J Radiat Oncol Biol Phys. 2025 Mar
26:S0360-3016(25)00260-3. doi:
10.1016/j.ijrobp.2025.03.028. PMID:
40154848.
Observational study˰ ˍ
Saito R, Kanamori M, Arakawa Y, Mineharu Y, Aihara Y, Chiba K,
Kumabe T, Shibahara I, Sonoda Y, Matsuda K, Kinoshita M, Sato A,
Takahashi F, Tominaga T.
A Multicenter
Phase II Trial of Nimustine Hydrochloride Administered via
Convection-Enhanced Delivery in Children With DIPG.
Cancer
Sci. 2025 Mar 27. doi:
10.1111/cas.70054. PMID:
40150841. Interventional study.
ˍ
Srivastav
A, D'Souza PR, Pai K, Shetty SB, Aneja S, Ramesh PS.
Neurological
Conundrums: A Case Series on Brain Tumors Masquerading as
Psychiatric Disorders.
Indian
J Psychol Med.
2025 Mar 27:02537176251324471. doi:
10.1177/02537176251324471. PMID:
40162437. Case reports. ˍ
Ali H, Bajwa S, Durugu S, Prabhakaran SY, Saleem HMA, Bodrova E,
Santhi JLA, Thirumaran R.
EPR25-124:
Epidemiology of Giant Cell Glioblastoma: A Surveillance,
Epidemiology, and End Results (SEER) Analysis.
J
Natl Compr Canc Netw. 2025 Mar 28;23(3.5):EPR25-124.
doi:
10.6004/jnccn.2024.7325. PMID:
40159141. Observational
study˰ ˍ
Chang HJ, Ke CH, Wang YS, Kuo YC.
Case
Report: Effective management of residual glioblastoma with
combined modality therapy.
Front
Oncol. 2025 Mar 28;15:1451408. doi:
10.3389/fonc.2025.1451408. PMID:
40224189. Case report. ˍ
Santhi JLA, Ali H, Vegivinti CTR, Bodrova E, Mehta M, Varghese RS,
Sriram V, Thirumaran R.
EPR25-138:
Glioblastoma Multiforme: A SEER STAT Analysis of Epidemiological,
Laterality, and Anatomical Prognostic Indicators.
J
Natl Compr Canc Netw. 2025 Mar 28;23(3.5):EPR25-138.
doi:
10.6004/jnccn.2024.7312. PMID:
40154441. Observational
study˰ ˍ
Fleming JL, Pugh SL, Chang SM, McElroy JP, Becker AP, Aldape KD,
Shih HA, Ashby LS, Hunter GK, Bahary JP, Schultz CJ, Kavanagh BD,
Puduvalli VK, Robins HI, Werner-Wasik M, Mehta M, Chakravarti A.
Comprehensive Molecular Analysis in
NRG Oncology/RTOG 9813: A Phase III Study of Radiation and
Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic
Astrocytoma.
Int
J Radiat Oncol Biol Phys. 2025 Mar
29:S0360-3016(25)00284-6. doi:
10.1016/j.ijrobp.2025.03.043. PMID:
40164352. Interventional study˰
ˍ
Bertucci
A, Dufour O, Appay R, Harlay V, Ducray F, Bronnimann C, Djelad A,
Cohen-Jonathan Moyal E, Campone M, Langlois O, Ducloie M, Vauleon
E, Younan N, Desenclos C, Ramirez C, Touat M, Idbaih A, Bequet C,
Figarella-Branger D, Dehais C, Chinot O, Tabouret E; POLA network.
Characteristics,
outcome, and prognostic factors of young patients with central
nervous system World Health Organization grade 3
oligodendrogliomas IDH-mutant and 1p/19q codeleted: A French POLA
network study.
Cancer.
2025 Mar 30;131(7):e35814. doi:
10.1002/cncr.35814. PMID:
40159303. Observational study. ˍ
Riegel
DC, Bureau BL, Conlon P, Chavez G, Connelly JM.
Long-term
survival, patterns of progression, and patterns of use for
patients with newly diagnosed glioblastoma treated with or without
Tumor Treating Fields (TTFields) in a real-world setting.
J
Neurooncol.
2025 Mar 31. doi:
10.1007/s11060-025-04946-w. PMID:
40163248. Observational study. ˍ
Siddiq Z, Gilani A, Ung TH, Kleinschmidt-DeMasters BK.
Isocitrate
dehydrogenase-mutant astrocytoma in persons aged 55 years and
older: Survival differences versus the young.
J
Neuropathol Exp Neurol. 2025 Mar 28:nlaf024. doi:
10.1093/jnen/nlaf024. PMID:
40156602.
Observational study. ˍ
Ellenbogen Y, Zadeh G.
A new paradigm
for immunotherapy in glioblastoma.
Nat
Med. 2025 Mar 31. doi:
10.1038/s41591-025-03607-9. PMID:
40164727. Case report˰
ˍ
Taori S, Wei Z, Hadjipanayis CG, Niranjan A, Lunsford LD.
Long-term outcomes following upfront
single-session gamma knife stereotactic radiosurgery for large
volume meningiomas.
J
Neurooncol. 2025 Mar 31. doi:
10.1007/s11060-025-05000-5. PMID:
40163246. Observational
study˰ ˍ
van Ommen F, van Genechten T, Willemsen-Bosman ME, Peters M,
Seravalli E, van der Lugt J, Nievelstein RAJ, Mueller S, Hulleman
E, van Vuurden DG, Kranendonk MEG, Hoving EW, Hoeben BAW, Janssens
GO.
Gross tumor volume increase and
need for adaptive radiotherapy in pediatric-type diffuse
high-grade glioma of the midline structures.
Radiother
Oncol. 2025 Mar 31;207:110873. doi:
10.1016/j.radonc.2025.110873. PMID:
40174703.
Observational study. ˍ